High Amphipathicity of α-helical Peptides Enhances Unmethylated CpG DNA-induced Activation of Mouse Macrophage-like RAW264.7 Cells

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jul 15

PMID 39009614

Authors

Saeka Nishihara

Nao Nakamura

Kiyoshi Kawasaki

Affiliations

Soon will be listed here.

Abstract

The α-helical antimicrobial peptide Kn2-7 enhances the activation of mouse macrophage-like RAW264.7 induced by DNA containing unmethylated cytosine-guanine motifs (CpG DNA). This enhancement is related to increased cellular uptake of DNA by Kn2-7, but the relevant properties of Kn2-7 are unknown. Physicochemical property analysis revealed that Kn2-7 has high amphipathicity. In contrast, the α-helical antimicrobial peptide L5, which increases the cellular uptake of CpG DNA but does not enhance CpG DNA-induced activation, has low amphipathicity. Kn2-7 derivatives with decreased amphipathicity but the same amino acid composition as Kn2-7 did not enhance CpG DNA-induced activation. On the other hand, L5 derivatives with high amphipathicity but the same amino acid composition as L5 enhanced CpG DNA-induced activation. Cellular uptake of DNA was not increased by the L5 derivatives, indicating that high amphipathicity does not affect DNA uptake. Furthermore, α-helical peptides with reversed sequences relative to the Kn2-7 and L5 derivatives with high amphipathicity were synthesized. The reversed-sequence peptides, which had the same amphipathicity but different amino acid sequences from their counterparts, enhanced CpG DNA-induced activation. Taken together, these observations indicate that the high amphipathicity of α-helical peptides enhances the CpG DNA-induced activation of RAW264.7.

References

Holzwarth G, Doty P . THE ULTRAVIOLET CIRCULAR DICHROISM OF POLYPEPTIDES. J Am Chem Soc. 1965; 87:218-28. DOI: 10.1021/ja01080a015. View

Manabe T, Kawasaki K . D-form KLKLLLLLKLK-NH peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components. Sci Rep. 2017; 7:43384. PMC: 5338256. DOI: 10.1038/srep43384. View

Kumagai Y, Takeuchi O, Akira S . TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev. 2008; 60(7):795-804. DOI: 10.1016/j.addr.2007.12.004. View

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

Krieg A . Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006; 5(6):471-84. DOI: 10.1038/nrd2059. View

Klinman D . Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol. 2004; 4(4):249-58. DOI: 10.1038/nri1329. View

Buck M . Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q Rev Biophys. 1999; 31(3):297-355. DOI: 10.1017/s003358359800345x. View

Scott M, Vreugdenhil A, Buurman W, Hancock R, Gold M . Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol. 2000; 164(2):549-53. DOI: 10.4049/jimmunol.164.2.549. View

Eisenberg D, Weiss R, Terwilliger T . The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature. 1982; 299(5881):371-4. DOI: 10.1038/299371a0. View

10.

Qu Y, Yang J, Zhan P, Liu S, Zhang K, Jiang Q . Self-Assembled DNA Dendrimer Nanoparticle for Efficient Delivery of Immunostimulatory CpG Motifs. ACS Appl Mater Interfaces. 2017; 9(24):20324-20329. DOI: 10.1021/acsami.7b05890. View

11.

Lee E, Lee M, Wong G . Modulation of toll-like receptor signaling by antimicrobial peptides. Semin Cell Dev Biol. 2018; 88:173-184. PMC: 6087683. DOI: 10.1016/j.semcdb.2018.02.002. View

12.

Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A . Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem. 1996; 271(30):18188-93. DOI: 10.1074/jbc.271.30.18188. View

13.

Latz E, Verma A, Visintin A, Gong M, Sirois C, Klein D . Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol. 2007; 8(7):772-9. DOI: 10.1038/ni1479. View

14.

Zasloff M . Antimicrobial peptides of multicellular organisms. Nature. 2002; 415(6870):389-95. DOI: 10.1038/415389a. View

15.

Matsuzaki K . Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta. 2008; 1788(8):1687-92. DOI: 10.1016/j.bbamem.2008.09.013. View

16.

Nishihara S, Kawasaki K . Enhanced cellular uptake of CpG DNA by α-helical antimicrobial peptide Kn2-7: Effects on macrophage responsiveness to CpG DNA. Biochem Biophys Res Commun. 2020; 530(1):100-106. DOI: 10.1016/j.bbrc.2020.07.013. View

17.

Du R, Cedrone E, Romanov A, Falkovich R, Dobrovolskaia M, Bathe M . Innate Immune Stimulation Using 3D Wireframe DNA Origami. ACS Nano. 2022; 16(12):20340-20352. PMC: 10144931. DOI: 10.1021/acsnano.2c06275. View

18.

Gautier R, Douguet D, Antonny B, Drin G . HELIQUEST: a web server to screen sequences with specific alpha-helical properties. Bioinformatics. 2008; 24(18):2101-2. DOI: 10.1093/bioinformatics/btn392. View

19.

Lai Y, Adhikarakunnathu S, Bhardwaj K, Ranjith-Kumar C, Wen Y, Jordan J . LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One. 2011; 6(10):e26632. PMC: 3198786. DOI: 10.1371/journal.pone.0026632. View

20.

Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y . Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. PLoS One. 2012; 7(7):e40135. PMC: 3390344. DOI: 10.1371/journal.pone.0040135. View